Onsdag 28 Oktober | 16:03:11 Europe / Stockholm
Est. tid*
2026-07-28 - Kvartalsrapport 2026-Q2
2026-05-05 - X-dag ordinarie utdelning EL 4.00 EUR
2026-04-28 - Extra Bolagsstämma
2026-04-28 - Årsstämma
2026-02-11 - Bokslutskommuniké 2025
2025-07-28 - Kvartalsrapport 2025-Q2
2025-05-07 - X-dag ordinarie utdelning EL 3.95 EUR
2025-04-30 - Årsstämma
2025-04-30 - Extra Bolagsstämma
2025-02-12 - Bokslutskommuniké 2024
2024-07-25 - Kvartalsrapport 2024-Q2
2024-05-03 - X-dag ordinarie utdelning EL 3.95 EUR
2024-04-30 - Extra Bolagsstämma
2024-04-30 - Årsstämma
2024-02-14 - Bokslutskommuniké 2023
2023-07-26 - Kvartalsrapport 2023-Q2
2023-05-22 - X-dag ordinarie utdelning EL 3.23 EUR
2023-05-17 - Extra Bolagsstämma
2023-05-17 - Årsstämma
2023-03-10 - Bokslutskommuniké 2022
2022-07-29 - Kvartalsrapport 2022-Q2
2022-05-30 - X-dag ordinarie utdelning EL 2.51 EUR
2022-05-25 - Extra Bolagsstämma
2022-05-25 - Årsstämma
2022-03-11 - Bokslutskommuniké 2021
2021-07-30 - Kvartalsrapport 2021-Q2
2021-05-28 - X-dag halvårsutdelning EL 1.08
2021-05-21 - Extra Bolagsstämma
2021-05-21 - Årsstämma
2021-03-12 - Bokslutskommuniké 2020
2020-12-23 - X-dag bonusutdelning EL 1.15
2020-06-25 - Extra Bolagsstämma
2020-06-25 - Årsstämma
2019-10-30 - Kvartalsrapport 2019-Q3
LandFrankrike
SektorHandel & varor
IndustriDetaljhandel
EssilorLuxottica är specialiserat inom tillverkning och design av linser. Inom koncernen återfinns ett flertal varumärken, där de mer kända inkluderar Crizal, Varilux samt Essilor. Utöver erbjuds även helhetslösningar med ramar och glasögon för personligt bruk, men även för industriell användning. Verksamhet innehas på global nivå, huvudsakligen runtom Nordamerika och Europa, med privata kunder som dominerande kundbas.

All ägardata du vill ha finns i Holdings!

EssilorLuxottica: Q3 2026 Revenue - Revenue growth at 9.0% in Q3, +7.2% at constant currency

2026-10-20 18:00:00

Revenue growth at 9.0% in Q3, +7.2% at constant currency

  • Group revenue +9.0% to Euro 7,486 million in Q3, +7.2% at constant ER1 on top of double-digit growth of last year
  • Group revenue +6.8% to Euro 22,304 million in the first nine months of the year, +8.9% at constant ER1
  • Direct to Consumer up 10.6%1 in Q3, with comparable-store sales3 at +6.8%
  • Professional Solutions up 3.4%1, compared to double-digit growth of last year
  • All the regions contributing to the Group’s growth, with EMEA DTC and Asia-Pacific up double digits1
  • Traditional business (Eyecare & Medtech) marching at >6%1 pace in both three and nine months
  • Myopia management portfolio up 24%1 in the three and nine months
  • Wearables (AI glasses and Nuance Audio) up 20%1 in revenue in Q3
  • Nuance Audio Plus launched in mid-September, improving product effectiveness and user experience

Paris, France (October 20, 2026 - 6:00 pm) – EssilorLuxottica announced today that consolidated revenue for the third quarter of 2026 reached Euro 7,486 million, representing a year-on-year increase of 7.2% at constant exchange rates1 compared to the third quarter of 2025 (+9.0% at current exchange rates).

Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO at EssilorLuxottica commented: “Quarter after quarter, our Company continues to demonstrate the strength of its unique model. In the third quarter, we delivered 9% revenue growth, with all regions contributing and Asia-Pacific standing out with double-digit growth. Our eyecare, eyewear and medtech activities remained a powerful engine of growth, up over 6% in both the quarter and the first nine months of the year, while wearables’ revenue increased 20%, confirming the strong momentum behind this emerging category we continue to lead.

Our myopia management portfolio continued its exceptional trajectory, growing 24% in both the quarter and year to date. As we head into the holiday season, new AI glasses launches and the rollout of Nuance Audio Plus are further strengthening our wearable portfolio, offering people new ways to engage with and navigate the world around them. We were also proud to see Stellest recognized by TIME among the Best Inventions of the Year, highlighting the impact our innovation has in addressing one of the most pressing health challenges of our time and improving the lives of millions of children worldwide.

Above all, these achievements reflect the passion, talent and commitment of our people around the world. Their ability to strengthen the business that defines us today while accelerating our expansion across science, clinical care and surgery sets EssilorLuxottica apart and gives us great confidence in the future.”